MAXCYTE, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Maxcyte, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2024.
  • Maxcyte, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$9.38M, a 10.8% increase year-over-year.
  • Maxcyte, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$35.4M, a 8.56% decline year-over-year.
  • Maxcyte, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$37.9M, a 60.9% decline from 2022.
  • Maxcyte, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$23.6M, a 23.5% decline from 2021.
  • Maxcyte, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$19.1M, a 61.5% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$35.4M -$9.38M +$1.14M +10.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 -$36.6M -$9.53M +$1.36M +12.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-06
Q4 2023 -$37.9M -$5.28M -$467K -9.72% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$37.5M -$11.3M -$4.82M -74.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$32.6M -$10.5M -$2.25M -27.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 -$30.4M -$10.9M -$6.81M -168% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-06
Q4 2022 -$23.6M -$4.81M +$64.6K +1.33% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$23.6M -$6.43M -$3.75M -140% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$19.9M -$8.26M -$3.84M -86.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$16M -$4.07M +$3.04M +42.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$19.1M -$4.87M -$2.22M -83.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$16.9M -$2.68M +$418K +13.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$17.3M -$4.42M -$1.42M -47.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-09
Q1 2021 -$15.9M -$7.11M -$4.04M -132% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-09
Q4 2020 -$11.8M -$2.65M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-22
Q3 2020 -$3.1M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$3M Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-10
Q1 2020 -$3.06M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.